RxDoctor Payments Data

Paravasthu Ramanujam, MD

Colon & Rectal Surgery · Sun City, AZNPI 1447286752

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (48.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Intuitive Surgical at 57.3% of the total. 2025 is the largest year on record at $7,537, 5.9 times the $1,279 reported in 2019.

$12,886in general payments, 2019–2025

Across 88 payments — averaging $146.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • AbbVie$2K
  • Davol Inc.$985
  • Creo Medical Inc.$871
  • TELA Bio, Inc.$756
  • Acacia Pharma Inc$215
  • plus $515 from 11 others

What the payments were for

  • Travel & lodging$3,84730%
  • Food & beverage$2,82422%
  • Education$6,21548%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,886 in reported general payments places this provider in the 65th percentile of 50 colon & rectal surgery providers in Arizona.

See all colon & rectal surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$125,831
Medicare patients
310
Services billed
538

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocortisone24$284
Neomycin Sulfate26$133
Metronidazole52$89
Ciprofloxacin Hcl25$44

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Sun City

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →